The biotech plans to start testing its malaria vaccine in clinical trials by the end of 2022, according to a July 26 news release.
As a part of its efforts to combat disease and death from malaria, BioNTech is also evaluating sustainable mRNA vaccine production capacities in Africa.
“The response to the pandemic has shown that science and innovation can transform people’s lives when all key stakeholders work together towards a common goal. We are committed to bringing our innovations to those who need them most,” BioNTech CEO Ugur Sahin, MD, PhD, said in the news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
